Skip to Content

Clinical Trials Detail

Multi-center, open-label randomized study of single or double myeloablative cord blood transplantation with or without infusion of off-the-shelf ex vivo expanded cryopreserved cord blood progenitor cells in patients with hematologic malignancies (2603.00)

Objective
This is a clinical trial of single or double myeloablative cord blood transplantation with or without infusion of off-the-shelf ex vivo expanded cryopreserved cord blood progenitor cells which will be administered intravenously or by infusion.
IRB Protocol Number
12-1501
Principal Investigator(s)
JONATHAN GUTMAN

Cancer Trials

  • Leukemia/Myelodysplasia
Sponsor(s)
Fred Hutchinson Cancer Research Center
Contact
DEREK SCHATZ at 720-848-0628
or DEREK.SCHATZ@UCDENVER.EDU
Eligibility and Other Participant Information
What To Expect : You will be on this study for about 2 years. // Eligibility include but are not limited to between 18 and 45 years old with leukemia or MDS